Health In Tech Statistics
Total Valuation
Health In Tech has a market cap or net worth of $68.15 million. The enterprise value is $57.95 million.
Important Dates
The next estimated earnings date is Monday, July 20, 2026, after market close.
| Earnings Date | Jul 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Health In Tech has 65.53 million shares outstanding. The number of shares has increased by 2.83% in one year.
| Current Share Class | 53.83M |
| Shares Outstanding | 65.53M |
| Shares Change (YoY) | +2.83% |
| Shares Change (QoQ) | +0.78% |
| Owned by Insiders (%) | 69.19% |
| Owned by Institutions (%) | 3.93% |
| Float | 20.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 897.90 |
| PS Ratio | 2.00 |
| Forward PS | 1.17 |
| PB Ratio | 3.16 |
| P/TBV Ratio | 4.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.13, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.13 |
| Quick Ratio | 2.61 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -4.52% and return on invested capital (ROIC) is -10.58%.
| Return on Equity (ROE) | -4.52% |
| Return on Assets (ROA) | -2.76% |
| Return on Invested Capital (ROIC) | -10.58% |
| Return on Capital Employed (ROCE) | -5.07% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $374,551 |
| Profits Per Employee | -$8,879 |
| Employee Count | 91 |
| Asset Turnover | 1.36 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -270,570 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +36.84% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +36.84% |
| 50-Day Moving Average | 1.22 |
| 200-Day Moving Average | 1.75 |
| Relative Strength Index (RSI) | 46.66 |
| Average Volume (20 Days) | 188,193 |
Short Selling Information
The latest short interest is 679,762, so 1.04% of the outstanding shares have been sold short.
| Short Interest | 679,762 |
| Short Previous Month | 560,340 |
| Short % of Shares Out | 1.04% |
| Short % of Float | 3.37% |
| Short Ratio (days to cover) | 2.45 |
Income Statement
In the last 12 months, Health In Tech had revenue of $34.08 million and -$808,031 in losses. Loss per share was -$0.02.
| Revenue | 34.08M |
| Gross Profit | 20.09M |
| Operating Income | -1.11M |
| Pretax Income | -1.08M |
| Net Income | -808,031 |
| EBITDA | n/a |
| EBIT | -1.11M |
| Loss Per Share | -$0.02 |
Full Income Statement Balance Sheet
The company has $10.33 million in cash and $121,595 in debt, giving a net cash position of $10.20 million or $0.16 per share.
| Cash & Cash Equivalents | 10.33M |
| Total Debt | 121,595 |
| Net Cash | 10.20M |
| Net Cash Per Share | $0.16 |
| Equity (Book Value) | 21.60M |
| Book Value Per Share | 0.33 |
| Working Capital | 15.04M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -712,787 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 58.95%, with operating and profit margins of -3.26% and -2.37%.
| Gross Margin | 58.95% |
| Operating Margin | -3.26% |
| Pretax Margin | -3.16% |
| Profit Margin | -2.37% |
| EBITDA Margin | n/a |
| EBIT Margin | -3.26% |
| FCF Margin | n/a |
Dividends & Yields
Health In Tech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.83% |
| Shareholder Yield | -2.83% |
| Earnings Yield | -1.19% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for Health In Tech is $4.03, which is 287.50% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.03 |
| Price Target Difference | 287.50% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Health In Tech has an Altman Z-Score of 9.6 and a Piotroski F-Score of 2.
| Altman Z-Score | 9.6 |
| Piotroski F-Score | 2 |